GW Pharma soars CBD-based drug step closer to commercial launch

Marijuana stocks ripped higher Thursday after the U.S. Drug Enforcement Administration classified a cannabidiol (CBD)-based drug made by GW Pharmaceuticals in its least restrictive category, setting the stage for commercial launch.

Source

The post GW Pharma soars CBD-based drug step closer to commercial launch appeared first on Cannabis Stock Picks.

Go to OG News Source
Author: Admin
{authorlink}